High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer’s Disease in Human Cerebrospinal Fluid

Disease modifying treatments for Alzheimer’s disease (AD) constitute a major goal in medicine. Current trends suggest that biomarkers reflective of AD neuropathology and modifiable by treatment would provide supportive evidence for disease modification. Nevertheless, a lack of quantitative tools to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendrickson, Ronald C., Lee, Anita Y. H., Song, Qinghua, Liaw, Andy, Wiener, Matt, Paweletz, Cloud P., Seeburger, Jeffrey L., Li, Jenny, Meng, Fanyu, Deyanova, Ekaterina G., Mazur, Matthew T., Settlage, Robert E., Zhao, Xuemei, Southwick, Katie, Du, Yi, Holder, Dan, Sachs, Jeffrey R., Laterza, Omar F., Dallob, Aimee, Chappell, Derek L., Snyder, Karen, Modur, Vijay, King, Elizabeth, Joachim, Catharine, Bondarenko, Andrey Y., Shearman, Mark, Soper, Keith A., Smith, A. David, Potter, William Z., Koblan, Ken S., Sachs, Alan B., Yates, Nathan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535975/
https://www.ncbi.nlm.nih.gov/pubmed/26270474
http://dx.doi.org/10.1371/journal.pone.0135365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535975/
https://www.ncbi.nlm.nih.gov/pubmed/26270474
http://dx.doi.org/10.1371/journal.pone.0135365

Ejemplares similares